BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8699 related articles for article (PubMed ID: 25557335)

  • 1. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFNgamma, TNFalpha and IL-1beta on viability, butyrate oxidation and IL-8 secretion.
    Pedersen G; Saermark T; Bendtzen K; Brynskov J
    Autoimmunity; 2000 Dec; 32(4):255-63. PubMed ID: 11191284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
    Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
    Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
    Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
    Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial expression of interleukin-37b in inflammatory bowel disease.
    Imaeda H; Takahashi K; Fujimoto T; Kasumi E; Ban H; Bamba S; Sonoda H; Shimizu T; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2013 Jun; 172(3):410-6. PubMed ID: 23600829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the mucosal immune system in inflammatory bowel disease.
    MacDermott RP
    J Gastroenterol; 1996 Dec; 31(6):907-16. PubMed ID: 9027661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.
    Østvik AE; Svendsen TD; Granlund AVB; Doseth B; Skovdahl HK; Bakke I; Thorsvik S; Afroz W; Walaas GA; Mollnes TE; Gustafsson BI; Sandvik AK; Bruland T
    J Crohns Colitis; 2020 Jul; 14(7):920-934. PubMed ID: 32020185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens.
    Velikova T; Kyurkchiev D; Spassova Z; Karakolev I; Ivanova-Todorova E; Altankova I; Stanilova S
    Cytokine; 2017 Apr; 92():12-19. PubMed ID: 28088612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-γ and IL-17A regulate intestinal crypt production of CXCL10 in the healthy and inflamed colon.
    Walrath T; Malizia RA; Zhu X; Sharp SP; D'Souza SS; Lopez-Soler R; Parr B; Kartchner B; Lee EC; Stain SC; Iwakura Y; O'Connor W
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G479-G489. PubMed ID: 31790273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts.
    Takahashi K; Imaeda H; Fujimoto T; Ban H; Bamba S; Tsujikawa T; Sasaki M; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2013 Aug; 173(2):323-31. PubMed ID: 23607908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis.
    Saiz-Gonzalo G; Hanrahan N; Rossini V; Singh R; Ahern M; Kelleher M; Hill S; O'Sullivan R; Fanning A; Walsh PT; Hussey S; Shanahan F; Nally K; O'Driscoll CM; Melgar S
    Front Immunol; 2021; 12():655960. PubMed ID: 34394073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.
    Panja A; Goldberg S; Eckmann L; Krishen P; Mayer L
    J Immunol; 1998 Oct; 161(7):3675-84. PubMed ID: 9759892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium.
    Pedersen G; Saermark T; Kirkegaard T; Brynskov J
    Clin Exp Immunol; 2009 Feb; 155(2):257-65. PubMed ID: 19137636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
    Shioya M; Nishida A; Yagi Y; Ogawa A; Tsujikawa T; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2007 Sep; 149(3):480-6. PubMed ID: 17590175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation.
    Uo M; Hisamatsu T; Miyoshi J; Kaito D; Yoneno K; Kitazume MT; Mori M; Sugita A; Koganei K; Matsuoka K; Kanai T; Hibi T
    Gut; 2013 Dec; 62(12):1734-44. PubMed ID: 23013725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
    Adachi M; Kurotani R; Morimura K; Shah Y; Sanford M; Madison BB; Gumucio DL; Marin HE; Peters JM; Young HA; Gonzalez FJ
    Gut; 2006 Aug; 55(8):1104-13. PubMed ID: 16547072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases.
    Wallace JW; Constant DA; Nice TJ
    Front Immunol; 2021; 12():767505. PubMed ID: 34712246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 435.